Literature DB >> 3303162

The management of primary lymphoma of bone.

N P Mendenhall, J J Jones, B S Kramer, T M Hudson, R L Carter, W F Enneking, R B Marcus, R R Million.   

Abstract

From October 1962 through April 1982, 21 patients with the diagnosis of primary lymphoma of bone (18 monostotic, stages IE and IIE; 3 polyostotic) were treated with curative intent. A combination of chemotherapy and radiation therapy was used in 11 patients, local treatment alone in 9 patients, and chemotherapy alone in one patient. Overall 5-year survival for the patients treated with curative intent was 56%. Standard work-up has changed over the 20-year study period. Five-year survival for the subset of eight stage I and II patients with full pretherapy staging was 83%. Prognosis was significantly correlated with extent of pretherapy staging. Treatment parameters that also seemed to predict outcome were the aggressiveness of chemotherapy and the use of irradiation or surgery for local-regional disease; the only local failure occurred in the patient who received chemotherapy alone. Complications of radiation therapy alone and in combination with chemotherapy are discussed and correlated with irradiation dose. Radiation therapy techniques are described, and a management approach is recommended.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3303162     DOI: 10.1016/s0167-8140(87)80201-3

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

1.  Newly developed multiple myeloma in a patient with primary T-cell lymphoma of bone.

Authors:  Jun-Eul Hwang; Sang-Hee Cho; Ok-Ki Kim; Hyun-Jeong Shim; Se-Ryeon Lee; Jae-Sook Ahn; Duk-Hwan Yang; Yeo-Kyeoung Kim; Je-Jung Lee; Hyeoung-Joon Kim; Ik-Joo Chung
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

2.  Primary bony involvement in Hodgkin's disease.

Authors:  R MacCormick; A Covert; M Gross
Journal:  CMAJ       Date:  1989-05-01       Impact factor: 8.262

3.  Primary bone lymphoma: Clinical presentation and therapeutic considerations.

Authors:  Annika Müller; Martin Dreyling; Falk Roeder; Andrea Baur-Melnyk; Thomas Knösel; Alexander Klein; Christof Birkenmaier; Volkmar Jansson; Hans Roland Dürr
Journal:  J Bone Oncol       Date:  2020-09-28       Impact factor: 4.072

4.  Primary non-Hodgkin's lymphoma of the bone: a single institution experience.

Authors:  C Deshmukh; A Bakshi; P Parikh; R Nair; V Pai; S Gupta; A Shaikh; M Muckaden; K Naresh; T Saikia
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

5.  MR imaging characteristics in primary lymphoma of bone with emphasis on non-aggressive appearance.

Authors:  Fenna H Heyning; Herman M J A Kroon; Pancras C W Hogendoorn; Antonie H M Taminiau; Henk-Jan van der Woude
Journal:  Skeletal Radiol       Date:  2007-06-09       Impact factor: 2.199

6.  Localised lymphoma of bone: prognostic factors and treatment recommendations. The Princess Margaret Hospital Lymphoma Group.

Authors:  A J Rathmell; M K Gospodarowicz; S B Sutcliffe; R M Clark
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

7.  Primary lymphoma of bone--survival and prognosis.

Authors:  Jun Yong Choi; Jee Sook Hahn; Chang Ok Suh; Woo Ick Yang
Journal:  Korean J Intern Med       Date:  2002-09       Impact factor: 2.884

8.  Extranodal presentation of Hodgkin's lymphoma of the sternum: A case report and review of the literature.

Authors:  Yan Li; You Qin; Liduan Zheng; Hong Liu
Journal:  Oncol Lett       Date:  2017-12-07       Impact factor: 2.967

9.  Beneficial effect of consolidative radiotherapy for patients with lymphoma and skeletal involvement.

Authors:  Yin Xiao; Fang Zhu; Tao Liu; Qiuhui Li; Xiaoqian Li; Gang Wu; Juan Li; Liling Zhang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.